- Home
- BNL vs ALVO Comparison
BNL vs ALVO Comparison
Compare BNL & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNL
- ALVO
- Stock Information
- Founded
- BNL 2007
- ALVO 2013
- Country
- BNL United States
- ALVO Luxembourg
- Employees
- BNL N/A
- ALVO N/A
- Industry
- BNL Real Estate Investment Trusts
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- BNL Real Estate
- ALVO Health Care
- Exchange
- BNL Nasdaq
- ALVO Nasdaq
- Market Cap
- BNL 3.0B
- ALVO 3.4B
- IPO Year
- BNL 2020
- ALVO N/A
- Fundamental
- Price
- BNL $15.93
- ALVO $8.37
- Analyst Decision
- BNL Hold
- ALVO Buy
- Analyst Count
- BNL 6
- ALVO 1
- Target Price
- BNL $18.60
- ALVO $18.00
- AVG Volume (30 Days)
- BNL 1.6M
- ALVO 151.4K
- Earning Date
- BNL 04-30-2025
- ALVO 05-20-2025
- Dividend Yield
- BNL 7.25%
- ALVO N/A
- EPS Growth
- BNL 3.57
- ALVO N/A
- EPS
- BNL 0.86
- ALVO N/A
- Revenue
- BNL $431,800,000.00
- ALVO $491,978,000.00
- Revenue This Year
- BNL $5.31
- ALVO $33.92
- Revenue Next Year
- BNL $4.57
- ALVO $45.74
- P/E Ratio
- BNL $18.64
- ALVO N/A
- Revenue Growth
- BNL N/A
- ALVO 426.85
- 52 Week Low
- BNL $13.96
- ALVO $7.35
- 52 Week High
- BNL $19.15
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- BNL 47.02
- ALVO 34.37
- Support Level
- BNL $15.73
- ALVO $8.04
- Resistance Level
- BNL $16.36
- ALVO $8.75
- Average True Range (ATR)
- BNL 0.62
- ALVO 0.56
- MACD
- BNL 0.05
- ALVO 0.06
- Stochastic Oscillator
- BNL 74.63
- ALVO 62.58
About BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.